Dr. Geary is EVP, Chief Development Officer of Drug Development at Ionis Pharmaceuticals. He is responsible for preclinical and clinical development of antisense drugs, regulatory affairs, as well as manufacturing. Since joining Ionis in 1995, Dr. Geary has been involved in discovery and development including the regulatory submission of more than thirty investigational new drug applications and multiple successful NDAs to U.S. and other regulatory agencies.

Dr. Geary received his Ph.D. in Biopharmaceutics from the University of Texas, College of Pharmacy, Austin, Texas and his B.S. in Biology from Texas A&M University, College Station, Texas

Richard retired from Ionis Pharmaceuticals in 2025.